# INTERVAL-GAP4 (NCT02730338)

> INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer (INTERVAL - GAP4)

No report yet. It can be ordered.

- Drugs tested: none (the trial tests a strategy, not a drug)
- Indication: metastatic prostate cancer

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02730338
- Phase: NA
- Status: UNKNOWN
- Sponsor: Movember Foundation
- Conditions: Metastatic Prostate Cancer
- Interventions: High intensity aerobic and resistance training; Psychosocial support
- Enrollment: 866
- Primary outcome: Overall Survival

## Indexed commentary on INTERVAL-GAP4 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 2 YouTube videos
- 2 posts on X

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=interval-gap4-nct02730338